Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial

Dodick, DW; Lipton, RB; Silberstein, S; Goadsby, PJ; Biondi, D; Hirman, J; Cady, R; Smith, J

Dodick, DW (reprint author), Mayo Clin, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.

CEPHALALGIA, 2019; 39 (9): 1075

Abstract

Background Calcitonin gene-related peptide plays an important role in migraine pathophysiology. We evaluated eptinezumab, an intravenous (IV) anti-cal......

Full Text Link